Myriad Genetics, Inc. — Cash Flow Charts
2 years of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow
$2M
Free Cash Flow
$2M
Investing Cash Flow
$-27M
Financing Cash Flow
$64M
Capex
—
Acquisitions
$0
Stock Buybacks
—
Stock-Based Comp
$35M
D&A
$54M
SBC Allocated Expense
$35M
SBC Unrecognized Cost
—